ovarian endometrioid adenocarcinoma

The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.

Print

Disease Overview

An endometrioid adenocarcinoma arising from the ovary. It comprises 10% to 25% of all primary ovarian carcinomas. Grossly, endometrioid carcinoma may present as a cystic or solid mass. Microscopically, the tumor greatly resembles the appearance of the ordinary type of endometrial adenocarcinoma. As a group, endometrioid carcinoma has a prognosis twice as good as that of serous or mucinous carcinoma.


Synonyms

  • endometrioid adenocarcinoma of ovary
  • endometrioid adenocarcinoma of the ovary
  • endometrioid cancer of ovary
  • endometrioid cancer of the ovary
  • endometrioid carcinoma of ovary
  • endometrioid carcinoma of the ovary
  • endometrioid carcinoma ovary
  • endometrioid ovarian cancer
  • endometrioid ovary carcinoma
  • endometrium adenocarcinoma of ovary
  • ovarian endometrioid adenocarcinoma
  • ovarian endometrioid cancer
  • ovarian endometrioid carcinoma
  • ovary endometrium adenocarcinoma

GARD Disease Summary

The Genetic and Rare Diseases Information Center (GARD) has information and resources for patients, caregivers, and families that may be helpful before and after diagnosis of this condition. GARD is a program of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).

View report
Orphanet

Orphanet has a summary about this condition that may include information on the diagnosis, care, and treatment as well as other resources. Some of the information and resources are available in languages other than English. The summary may include medical terms, so we encourage you to share and discuss this information with your doctor. Orphanet is the French National Institute for Health and Medical Research and the Health Programme of the European Union.

View report